By Product:
The veterinary intravenous (IV) solutions market is segmented by product into crystalloids, colloids, and others. Crystalloids are expected to dominate the market due to their effectiveness in treating dehydration and shock in both companion and production animals. Colloids are also gaining traction for their ability to rapidly increase blood volume and improve circulation in critically ill animals.
By Animal Type (Companion Animals, Production Animals):
The market is segmented by animal type into companion animals and production animals. Companion animals, such as dogs and cats, account for a significant share of the market due to the growing pet ownership rates and increasing focus on pet healthcare. Production animals, including livestock and poultry, are also driving market growth as farmers are increasingly adopting IV solutions to improve herd health and productivity.
By Indication:
The indication segment includes dehydration, electrolyte imbalance, shock, and others. Dehydration is the most common indication for veterinary IV solutions, especially in cases of vomiting, diarrhea, or fever. Electrolyte imbalance is also a key indication, as it often accompanies dehydration and requires precise intravenous fluid therapy for correction.
By End-use:
The end-use segment comprises veterinary clinics, hospitals, and others. Veterinary clinics are the largest end-users of IV solutions, as they are the primary point of care for sick and injured animals. Veterinary hospitals also play a significant role in the market, particularly for the treatment of critically ill animals that require intensive fluid therapy.